FDA Inspection
Sandor A. Romero, MDSandor A. Romero, MD – FDA Inspection, Feb 13, 2018
Record Details
This FDA Inspection record concerns Sandor A. Romero, MD, with an inspection on February 13, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · cde530d4-0b59-444d-987c-c0552a558af6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1041077
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sandor A. Romero, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Sandor A. Romero, MD
- FDA Inspection 1182159 - 2022-10-14
- FDA Inspection 1116494 - 2019-12-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.